Severity of Illness Index

"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.

Descriptor ID	D012720
MeSH Number(s)	E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
Concept/Terms	Severity of Illness Index Severity of Illness Index Illness Index Severities Illness Index Severity Index Severities, Illness Index Severity, Illness

Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Surveys and Questionnaires [E05.318.308.980]
Health Surveys [E05.318.308.980.438]
Health Status Indicators [E05.318.308.980.438.475]
Patient Acuity [E05.318.308.980.438.475.456]
Severity of Illness Index [E05.318.308.980.438.475.456.500]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Surveys and Questionnaires [N05.715.360.300.800]
Health Surveys [N05.715.360.300.800.438]
Health Status Indicators [N05.715.360.300.800.438.375]
Patient Acuity [N05.715.360.300.800.438.375.364]
Severity of Illness Index [N05.715.360.300.800.438.375.364.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Surveys and Questionnaires [N06.850.520.308.980]
Health Surveys [N06.850.520.308.980.438]
Health Status Indicators [N06.850.520.308.980.438.475]
Patient Acuity [N06.850.520.308.980.438.475.364]
Severity of Illness Index [N06.850.520.308.980.438.475.364.500]

Below are MeSH descriptors whose meaning is related to "Severity of Illness Index".

Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.

Bar chart showing 1249 publications over 31 distinct years, with a maximum of 80 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	7	8	15
1997	0	12	12
1998	1	8	9
1999	2	18	20
2000	0	16	16
2001	2	15	17
2002	1	24	25
2003	1	34	35
2004	1	27	28
2005	2	31	33
2006	0	44	44
2007	3	42	45
2008	3	60	63
2009	10	43	53
2010	6	46	52
2011	6	45	51
2012	8	57	65
2013	12	58	70
2014	1	52	53
2015	10	70	80
2016	7	66	73
2017	6	73	79
2018	5	48	53
2019	4	66	70
2020	5	61	66
2021	3	30	33
2022	0	16	16
2023	0	17	17
2024	8	18	26
2025	1	28	29
2026	0	1	1

Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.

Ma KC, Surie D, Lauring AS, Martin ET, Leis AM, Papalambros L, Gaglani M, Columbus C, Gottlieb RL, Ghamande S, Peltan ID, Brown SM, Ginde AA, Mohr NM, Gibbs KW, Hager DN, Saeed S, Prekker ME, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Hough CL, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Parikh B, Exline MC, Vaughn IA, Ramesh M, Safdar B, Mosier J, Harris ES, Shapiro NI, Felzer J, Zhu Y, Grijalva CG, Halasa N, Chappell JD, Womack KN, Rhoads JP, Baughman A, Swan SA, Johnson CA, Rice TW, Casey JD, Blair PW, Han JH, Ellington S, Lewis NM, Thornburg N, Paden CR, Atherton LJ, Self WH, Dawood FS, DeCuir J. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. Clin Infect Dis. 2026 Mar 17; 82(3):e595-e603.

View in: PubMed
Hoesterey DT, Dang H, Markovic D, Buhr RG, Tashkin DP, Barr RG, Belperio JA, Bowler RP, Bleecker ER, Couper DJ, Criner GJ, Cooper CB, Doerschuk CM, Dransfield MT, Drummond MB, Fawzy A, Freeman CM, Han MK, Hansel NN, Hastie AT, Hoffman EA, Huang YJ, Kaner RJ, Kanner RE, Kim V, Krishnan JA, Martinez FJ, O'Neal WK, Ortega VE, Paine R, Shrivastav AK, Wells JM, Woodruff PG, Curtis JL, Barjaktarevic I. Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort. Ann Am Thorac Soc. 2025 Dec; 22(12):1881-1890.

View in: PubMed
Shah N, Katragkou A, Fortin O, Tomatis Souverbielle C, Santos Oren M, Sheth A, Calardo S, Hauger SB, Angelis D, Gagliardo C, Solaiman A, Erdem G, Harik N, Mulkey SB, Downey R, Ansusinha E, Chalak L, Chiu S, Di Pentima MC, S?nchez PJ, Teran PR. Predicting Severe Short-Term Neurologic Outcomes in Human Parechovirus Meningoencephalitis. Pediatrics. 2025 Oct 01; 156(4).

View in: PubMed
Lebwohl M, Gooderham MJ, Warren RB, Tha?i D, Foley P, Gottlieb AB, Torres T, Popmihajlov Z, Jou YM, Linaberry M, Daamen C, Griffiths CEM. Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasis. Clin Exp Dermatol. 2025 Sep 25; 50(10):2030-2036.

View in: PubMed
Sriram S, Jensen ET, Msall ME, Yi JX, Zhabotynski V, Joseph RM, Kuban KCK, Frazier JA, Hooper SR, Santos HP, Gogcu S, Dammann C, Dammann O, Shenberger J, Fry RC, O'Shea TM. Retinopathy of Prematurity and Neurodevelopmental and Quality-of-Life Outcomes at 10 Years of Age. Am J Perinatol. 2026 Apr; 43(5):691-706.

View in: PubMed
Ekuban FA, Gripshover TC, Ames P, Biswas K, Bolatimi OE, Abramson J, Iyer M, Luo J, Ekuban A, Hwang JY, Park JW, Banerjee M, Watson WH, Wahlang B, Bello D, Schlezinger JJ, McClain CJ, Cave MC. Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model. Toxicol Sci. 2025 Aug 01; 206(2):388-408.

View in: PubMed
Lo SB, Shin J, Holtze ME, Post KE, Eche-Ugwu IJ, Temel JS, Cooley ME, Greer JA. Characterization of multidimensional dyspnea in advanced lung cancer with moderate to severe dyspnea-related functional impairment: a latent profile analysis. Support Care Cancer. 2025 Jul 18; 33(8):700.

View in: PubMed
Aoyama BC, Collaco JM, Agarwal A, Akangire G, Austin ED, Bansal M, Bhandari A, Ioana Cristea A, Hayden LP, Levin JC, Manimtim WM, Miller AN, Moore PE, Popova AP, Rhein LM, Sheils CA, Abman SH, Baker CD, Dawson SK, Abul MH, Henningfeld JK, Lagatta JM, Siddaiah R, Stephenson N, Toprak D, McGrath-Morrow SA. Allergy and atopic phenotype are associated with earlier gestation and severity of respiratory symptoms in bronchopulmonary dysplasia. Pediatr Res. 2026 Jan; 99(1):209-214.

View in: PubMed
Tesh RA, Zahoor A, Banks J, Gallagher K, Eckhardt CA, Sun H, Karakis I, Katyal R, Williams J, Nayak C, Herlopian A, Ng MC, Greenblatt AS, Meyers E, Westmeijer M, Harrison DS, Ganglberger W, Fan T, Struck AF, Sheikh IS, Nascimento FA, Westover MB. Inter-Rater Reliability of EEG-Based Encephalopathy Grading. J Clin Neurophysiol. 2026 Mar 01; 43(3):237-244.

View in: PubMed
Tripathi S, McGarvey J, Montgomery V, Gharpure VP, Kashyap R, Walkey A, Bansal V, Boman K, Kumar VK, Kissoon N. Prevalence of Sepsis as Defined by Phoenix Sepsis Definition Among Children With COVID-19. Hosp Pediatr. 2025 Jul 01; 15(7):554-562.

View in: PubMed

People

Explore

Similar Concepts

Top Journals